Dr. Mundy is Professor of Medicine, Pharmacology, Orthopaedics and Cancer Biology at Vanderbilt University Medical Center. He is also John A. Oates Chair in Translational Medicine and Director of the Vanderbilt Center in Bone Biology at that institution. He was formerly Professor and Head, Division of Endocrinology and Metabolism and Heyser Professor of Bone and Mineral Metabolism at the University of Texas Health Science Center (1980-2001). Professor of Cellular and Structural Biology at University of Texas Health Science Center, San Antonio, Texas (2003-2006). He was also Assistant Dean for Clinical Research and Principal Investigator of the Frederic C. Bartter Clinical Research Unit at that institution, as well as Interim Director of the San Antonio Cancer Institute.
Dr. Mundy received his MB, BS degree from the University of Melbourne (1966) and his MD degree from the University of Tasmania (1973). He became a Member of the Royal Australasian College of Physicians (1970) and Fellow (1973). He did his medical residency at the Royal Hobart Hospital and then joined the University of Tasmania as Lecturer in Medicine (1970). He next moved to Rochester, New York as a postdoctoral fellow in Clinical Pharmacology (1972-1974) and then to the University of Connecticut where he was firstly Assistant and then Associate Professor of Medicine in the Division of Endocrinology and Metabolism (1974-1980). He was Board Certified in Internal Medicine (1975) and Endocrinology and Metabolism (1977).
He was awarded the Fuller Albright Award of the American Society of Bone & Mineral Research in 1982 and an NIH Merit Award in 1986. He received the William F. Neuman Award of the American Society for Bone & Mineral Research in 1999, and received the 1999 University of Texas Presidential Distinguished Scholars Award. He has been elected to both the American Society for Clinical Investigation (1980) and the Association of American Physicians (1986). He has served on the editorial boards of Journal of Biological Chemistry, Journal of NIH Research, Internal Medicine, Journal of Bone & Mineral Research, Journal of Clinical Endocrinology & Metabolism, Bone, and Calcified Tissue International, as well as the IBMS virtual journal, BoneKEy. Dr. Mundy founded two biotechnology startup companies for drug discovery for bone diseases, and two in other areas. He has been President of the American Society for Bone & Mineral Research (1996-7) and Chairman of the Research Grants Committee of the National Osteoporosis Foundation (1986-96). He is currently on the Board of Directors of the National Osteoporosis Foundation, the International Myeloma Foundation and the International Bone & Mineral Society, of which he was President (2003-05). He is one of the three founders of the Cancer and Bone Society (2004). He was a member of the Advisory Council of the National Institute of Arthritis and Musculo-Skeletal Disorders (1997-2001). He is in the 2nd percentile of all NIH grantees over the past 25 years in terms of extra-mural grant funding. The training program he has directed for the past 25 years has trained 160 post-doctoral fellows and graduate students in bone and mineral metabolism, many of whom have gone on to successful and prominent careers in academia and industry. His research interests include drug discovery in osteoporosis, the effects of tumors on the skeleton, and osteoclast and osteoblast biology. His publications number over 550 original articles, reviews and book chapters, and is an inventor on 35 issued patents. He has an h-index of 86, that is he has 86 publications that have been independently cited more than 86 times. His papers have been cited over 23,000 times in the biomedical literature. He has edited 2 books and has published 2 separate monographs on calcium homeostasis and bone remodeling and its disorders.